Rubius Therapeutics logo

Rubius Therapeutics

ID: 5313083

Rubius Therapeutics is a biotechnology company using stem cells to develop red blood cell cellular therapies.

4

Funding Rounds

$365.0m

Money raised

Overview

Rubius Therapeutics is a biotechnology company using stem cells to develop red blood cell cellular therapies.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding series

Funding Series Analysis

The company Rubius Therapeutics has raised a total of $120m in funding over 4 rounds.

Key Insights:

  • Rubuis Therapeutics , June 2017: $120m
  • Rubius Therapeutics funding round, March 2018: $100m
  • Rubius Therapeutics funding round, June 2017: $120m
  • Rubius Therapeutics Series A round, December 2015: $25m